YELODIM LIMITED
Company number 13937043 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
YELODIM LIMITED - Analysis Report
Company Number: 13937043
Analysis Date: 2025-07-29 19:24 UTC
Financial Health Assessment: YELODIM LIMITED
1. Financial Health Score: D
Explanation:
YELODIM LIMITED exhibits several concerning financial "symptoms" typical of a business in early-stage distress or undercapitalization. The persistent negative net assets and net current liabilities indicate financial strain, akin to a patient showing chronic signs of poor circulation (cash flow problems). While the company is not yet insolvent, these warning signs demand prompt attention to prevent deterioration.
2. Key Vital Signs (Core Financial Metrics):
| Metric | 2024 (£) | Interpretation |
|---|---|---|
| Fixed Assets | 58,485 | Stable long-term asset base, slight decrease from prior year; a "skeleton" of tangible resources. |
| Current Assets | 3,198 | Very low liquid assets ("cash and equivalents"), though improved from prior year (559). |
| Current Liabilities | 25,393 | High short-term obligations; company owes significantly more than it holds in liquid assets. |
| Net Current Assets (Working Capital) | -22,195 | Negative working capital signals liquidity "symptoms" — inability to cover short-term debts with current resources. |
| Creditors After One Year | 38,587 | Substantial long-term liabilities, indicating financial leverage or borrowed funds. |
| Net Assets (Shareholders’ Funds) | -3,377 | Negative equity position suggests accumulated losses or undercapitalization; akin to "low red blood cell count". |
| Number of Employees | 2 | Micro entity size; small operational scale limits financial flexibility. |
3. Diagnosis: Business Financial Health Overview
YELODIM LIMITED is a micro-entity operating in the real estate sector (buying and selling own real estate). The company's financial statements reveal persistent financial distress:
Liquidity Issues: The company’s current liabilities are substantially higher than current assets, demonstrating strained liquidity. This is like a patient with poor hydration—cash inflows are insufficient to meet immediate obligations, risking operational disruption.
Negative Equity: The shareholders' funds are negative, indicating that the company has accumulated losses that exceed its net assets. This condition is akin to a body with a nutrient deficiency, showing signs of structural weakness.
Stable Fixed Assets but Declining: Fixed assets have slightly declined, possibly due to depreciation or disposal, but remain the bulk of total assets. The company depends heavily on these assets to generate future income but lacks sufficient working capital.
No Audit and Filleted Accounts: The company uses micro-entity reporting exemptions, providing limited financial detail, which may obscure deeper issues like profitability or cash flow trends.
Small Scale: With only two employees, the company has limited operational capacity, which may constrain growth or recovery ability.
Overall, YELODIM LIMITED is in a precarious financial condition, showing symptoms of cash flow stress and undercapitalization. Immediate attention to liquidity management and capital structure is required to avoid worsening health.
4. Recommendations: Action Plan to Improve Financial Wellness
Improve Liquidity ("Hydration")
- Negotiate better payment terms with creditors to reduce short-term liabilities pressure.
- Accelerate receivables collection or increase cash reserves.
- Consider short-term financing options cautiously to bridge liquidity gaps.
Capital Injection or Restructuring ("Blood Transfusion")
- Inject new equity capital to restore positive net asset position.
- Explore shareholder loans or convertible instruments if equity injection is not immediately possible.
Cost Control and Efficiency Improvements
- Review operational expenses and reduce non-essential costs to preserve cash flow.
- Assess the value and utilization of fixed assets; consider selling underused assets to raise cash.
Strategic Business Review
- Evaluate business model viability given current financial constraints.
- Explore partnerships, joint ventures, or asset disposals to strengthen balance sheet.
Enhanced Financial Reporting and Monitoring
- Maintain thorough accounting records beyond micro-entity minimums to identify early warning signs.
- Regularly monitor key liquidity and solvency ratios to track improvements or deterioration.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.